2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with Pleurisy, Tuberculous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbate, E; Alemán, M; Balboa, L; Basile, J; Castagnino, J; de la Barrera, SS; Geffner, L; Musella, RM; Romero, MM; Sasiain, MC; Schierloh, P; Yokobori, N | 1 |
1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and Pleurisy, Tuberculous
Article | Year |
---|---|
NK cells from tuberculous pleurisy express high ICAM-1 levels and exert stimulatory effect on local T cells.
Topics: Adult; CD11a Antigen; CD56 Antigen; Cell Communication; Cysteine; Humans; Intercellular Adhesion Molecule-1; Interleukin-12; Interleukin-15; Interleukin-18; Killer Cells, Natural; Lipopolysaccharides; Lipoproteins; Middle Aged; Mycobacterium tuberculosis; Phosphotransferases (Phosphate Group Acceptor); T-Lymphocytes; Tuberculosis, Pleural | 2009 |